Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
21.29
-0.14 (-0.63%)
Oct 26, 2026, 10:27 AM EDT - Market open
Anika Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Anika Therapeutics stock have an average target of $23, which predicts a 8.06% increase from the current stock price of 21.29.
Price Target: $23 (+8.06%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Anika Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | Jul '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington | Barrington | Buy Maintains $23 | Buy | Maintains | $23 | +8.06% | Oct 22, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Initiates $21 → $23 | Buy | Initiates | $21 → $23 | +8.06% | Sep 18, 2026 |
Financial Forecast
Revenue This Year
121.64M
from 112.82M
Increased by 7.82%
Revenue Next Year
128.26M
from 121.64M
Increased by 5.44%
EPS This Year
1.05
from 0.11
Increased by 854.55%
EPS Next Year
0.95
from 1.05
Decreased by -9.52%
EPS and Forward PE are based on non-GAAP adjusted numbers.